Wes Johnson

Wes Johnson is a 30-year veteran of the medical device industry and has held several CFO, CEO, and Board positions over that time. He was the CFO for Urologix and later Spinal Concepts, raising private and public equity, as well as playing a key role in selling Spinal Concepts to Abbott. He spent three years in Europe as GM of Abbott Spine, S.A. prior to joining CardioKinetix as its CEO. While at CardioKinetix, Mr. Johnson raised $66 million in private equity, completed two clinical studies, and achieved the CE Mark for its novel heart failure device. Mr. Johnson is currently CEO and Director of Admittance Technologies, a start-up company pursuing a novel means of providing real-time heart blood volumes, and is a Director of AngioDynamics, Inc. (NASDAQ: ANGO).